Kei S. Tolliver
Fondatore presso VLP Therapeutics LLC
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Ryuji Ueno | M | 70 |
VLP Therapeutics LLC
 VLP Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services VLP Therapeutics LLC operates as a biopharmaceutical company. The firm focuses on developing preventative and therapeutic vaccines, as well as next generation targeted antibody agents to treat cancer and infectious diseases, such as malaria, dengue fever, zika virus-based diseases, and autoimmune. The company was founded by Wataru Akahata, Ryuji Ueno, Sachiko Kuno, Kei S. Tolliver and Misako Nakata in 2012 and is headquartered in Gaithersburg, MD. | 28 anni |
| Wataru Akahata | M | - |
VLP Therapeutics LLC
VLP Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services VLP Therapeutics LLC operates as a biopharmaceutical company. The firm focuses on developing preventative and therapeutic vaccines, as well as next generation targeted antibody agents to treat cancer and infectious diseases, such as malaria, dengue fever, zika virus-based diseases, and autoimmune. The company was founded by Wataru Akahata, Ryuji Ueno, Sachiko Kuno, Kei S. Tolliver and Misako Nakata in 2012 and is headquartered in Gaithersburg, MD. | 12 anni |
| Misako Nakata | F | - |
VLP Therapeutics LLC
VLP Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services VLP Therapeutics LLC operates as a biopharmaceutical company. The firm focuses on developing preventative and therapeutic vaccines, as well as next generation targeted antibody agents to treat cancer and infectious diseases, such as malaria, dengue fever, zika virus-based diseases, and autoimmune. The company was founded by Wataru Akahata, Ryuji Ueno, Sachiko Kuno, Kei S. Tolliver and Misako Nakata in 2012 and is headquartered in Gaithersburg, MD. | 12 anni |
| Sachiko Kuno | M | 69 |
VLP Therapeutics LLC
VLP Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services VLP Therapeutics LLC operates as a biopharmaceutical company. The firm focuses on developing preventative and therapeutic vaccines, as well as next generation targeted antibody agents to treat cancer and infectious diseases, such as malaria, dengue fever, zika virus-based diseases, and autoimmune. The company was founded by Wataru Akahata, Ryuji Ueno, Sachiko Kuno, Kei S. Tolliver and Misako Nakata in 2012 and is headquartered in Gaithersburg, MD. | 12 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Matthias Alder | M | 59 | 3 anni | |
| Peter Greenleaf | M | 54 | 4 anni | |
| Timothy Maudlin | M | 73 | 7 anni | |
| Stanley G. Miele | M | 60 | - | |
| Matthew Donley | M | 55 | 4 anni | |
| Anthony C. Celeste | M | 85 | 8 anni | |
| Gayle Robert Dolecek | M | 81 | - | |
| Michael J. Jeffries | M | 80 | - | |
| Elizabeth Cho-Fertikh | M | - |
VLP Therapeutics LLC
VLP Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services VLP Therapeutics LLC operates as a biopharmaceutical company. The firm focuses on developing preventative and therapeutic vaccines, as well as next generation targeted antibody agents to treat cancer and infectious diseases, such as malaria, dengue fever, zika virus-based diseases, and autoimmune. The company was founded by Wataru Akahata, Ryuji Ueno, Sachiko Kuno, Kei S. Tolliver and Misako Nakata in 2012 and is headquartered in Gaithersburg, MD. | 5 anni |
| Taryn R. Joswick | F | - | - | |
| Hidetoshi Mine | M | 73 | - | |
| Charles S. Hrushka | M | 72 | - | |
| Myra Louise | M | - | - | |
| V. Molina | F | 75 | 3 anni | |
| Mariam Morris | F | 55 | 5 anni | |
| P. Christopher Holland | M | - | - | |
| Brad E. Fackler | M | 70 | 4 anni | |
| Steven Caffé | M | - | 4 anni | |
| Cary Claiborne | M | 64 | 3 anni | |
| Peter Kiener | M | 72 | 4 anni | |
| Ronald W. Kaiser | M | 70 | 1 anni | |
| Jan Smilek | M | 57 | 3 anni | |
| John C. Wright | M | 76 | 1 anni | |
| Diana Halim | F | 47 | 3 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 28 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Kei S. Tolliver
- Contatti personali
